Baltic Export, Baltic States – CIS, Financial Services, Latvia, Markets and Companies, Medicine

Last year, the company's consolidated profit reached EUR 12.2 million, while unconsolidated profit exceeded EUR 11.4 million. The company had projected its 2014 consolidated profit to reach EUR 15 million, and unconsolidated profit – EUR 14 million.

The council points out that these currency losses are more proof as to how important further diversification of the company's market is in the development of Olainfarm.

Furthermore, taking into account the rapid increase in Olainfarm’s sales volumes over the past years, the council has already underlined the necessity to carefully follow the situation with the company's technological capacity.

The manufacturing process has undergone significant improvement over the past two years, however, the company has still a lot of tasks at hand in fixing its infrastructure, which will significantly improve the company's compliance with environmental protection standards, and attraction of funds, the council's report says.

Taking into account the necessity to keep investing (also with regard to infrastructure), as well as the unstable situation on the company's markets, the council sticks to the decision to halt distributing this year's profit in dividends.